The use of GLP-1 drugs for weight loss among Americans has increased significantly. According to a Gallup poll, 11% of adults reported using these medications, up from 3% two years ago. Medicare has recently approved access for some patients, which may lead to further increases in usage. PBS NewsHour's William Brangham spoke with Juliette Cubanski for more insights.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Medicare Expands Access to Weight Loss Drugs for Beneficiaries
A Gallup poll indicates that the percentage of American adults using GLP-1 drugs for weight loss has increased from 3% to 11% over the past two years. Medicare's recent approval for some beneficiaries to access these drugs may contribute to further growth in usage.
People
William Brangham
Juliette Cubanski
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Some Medicare beneficiaries eligible for weight loss drug discounts
Neutral Headline
Medicare Expands Access to Weight Loss Drugs for Beneficiaries